Breast Cancer
From the Journals
Breast cancer exacts high financial toll worldwide
The rate of financial toxicity was much higher in low- and middle-income countries – affecting 79% of patients.
From the Journals
Genomic clues to poor outcomes in young breast cancer patients
Compared with older women with early stage HR-positive breast cancer, women under 40 years of age had significantly higher frequencies of certain...
Latest News
‘Valid option’ for partial breast irradiation in breast cancer
Study authors suggest that 30 Gy in five daily fractions is a ‘valid option’ for patients who received lumpectomy for early breast cancer.
From the Journals
Radiotherapy for early breast cancer: Sharp cutoff at age 70
Radiation therapy was 50% less likely to be prescribed for patients age 70 and older with early-stage breast cancer.
Conference Coverage
Use of diagnostic mammograms is inconsistent, survey finds
Many employ diagnostic mammograms for posttreatment surveillance, but benefit is unknown.
News from the FDA/CDC
FDA OKs sacituzumab govitecan for HR+ metastatic breast cancer
Label expansion for the Trop-2–directed antibody-drug conjugate was based on the TROPICS-02 trial.
From the Journals
Race and geography tied to breast cancer care delays
A new study suggests that “treatment delays are alarmingly common in patients at high risk for breast cancer death, including young Black women...
From the Journals
Quality of life predicts chemo tolerance in early breast cancer
Although quality of life is recognized as a predictor of survival in patients with advanced cancer, the evidence is less clear in early-stage...
News
FDA OKs elacestrant for ESR1+ advanced, metastatic breast cancer
The agency also approved the Guardant360 CDx assay as a companion diagnostic to identify breast cancer patients who meet the treatment...
Latest News
Disparities in breast cancer deaths, MRI screening persist
Black women are more likely to develop more aggressive, premenopausal breast cancers, including triple-negative breast cancer, that are more...
From the Journals
More type 2 diabetes deaths from cancer than heart disease
In people with type 2 diabetes, cancer screening should get at least as much attention as CVD prevention.